[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MFYS - Conformation of Go-Live Date for Medify Remote

Shareholder Information:

Trading Symbol: MFYS
Current Share Price: $0.09
Website: www.medifysolutions.com

Volume: 50,500
Annual Hight: 0.49
Annual Low: 0.05

About The Company:

The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care.

Listed on Pink Sheets® LLC, Medify Incorporated parent company is one of the most exciting propositions in the technology sector today.

Providing connectivity application solutions with partners such as CM Isitel spa, Oracle, EMIS and BT, Medify continue to set the pace in growth and solutions across the sector. Group headquarters are in the UK, with a management presence in Italy, Spain, Switzerland and the US.

Medify International springboards into European Healthcare:

Remote technology company Medify International announced today that it is building on its UK collaboration with Oracle, the world's largest enterprise software company, and expanding across Europe.

Following the success of its collaborative approach with Oracle in delivering a tried and tested system for remote access to patient notes for the NHS in the UK, the company is now working with Oracle’s European operations through its overseas arm Medify International.

Commenting on the announcement, Jeremy Nettle, EMEA Business Development Director for Healthcare at Oracle, said: "Working closely with Medify in the UK we have successfully delivered remote access to patient notes for GPs in the NHS. This is new and exciting technology and we see remote access as an important and innovative way of supporting our clients with a broader range of services. This is an important opportunity for both organisations to bring about patient benefits through the use of new, emerging technology across Europe, and potentially on a wider scale."

Jonathan Bryant, Executive Chairman of Medify International, said: "I am absolutely delighted that Oracle believes not only in the technology but also the benefits of our teamwork. Over the past 18 months we have worked closely together to test and prove the remote delivery system in one of the most complex and demanding healthcare systems in the world, namely the NHS. I am confident that we will make strong and swift headway across Europe."

In Italy, Medify operates through CM Isitel, and Oracle will work with this group to deliver remote patient note access to Italy’s national health service.

Click Here For More Press Releases

Small Cap News based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by Small Cap News to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.Small Cap Newsis not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein.
Small Cap News was compensated $30,000 by a non-controlling third party for profile coverage. Small Cap News is not a registered investment adviser or broker/dealer. Small Cap News makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies` annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Small Cap News undertakes no obligation to update such statements.

Small Cap News · PO Box 8444 · Auroa, IL 60507